Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...

Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

Researchers identified two anoikis-related genes linked with CTEPH, and that may serve as diagnostic biomarkers or treatment ...

According to the NHS, atherosclerosis occurs when arteries become narrowed, making it difficult for blood to flow through ...

Taking place on February 14-16, 2025, in Washington, the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient conference is an interdisciplinary and ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

The Pulmonary Hypertension Association will offer a free, regional workshop for people affected by pulmonary hypertension in Charlotte, North Carolina on Saturday, March 22. The PHA Connects: PH ...

Low blood pressure is primarily a concern if it produces symptoms such as dizziness ... which is a medical emergency. Learn More Causes and Risk Factors of Low Blood Pressure What is considered low ...

Thurner syndrome (MTS) is a clinicopathological condition where the left common iliac vein is compressed by the overlying right common iliac artery, potentially leading to deep vein thrombosis (DVT) ...

Clinical worsening events are defined as all-cause death, non-planned PAH worsening-related ... 60 mg WINREVAIR is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, ...

Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...